Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 719 | 289,590 | 3,124 | 40,997 | 5,164 |
| Gross Profit | 719 | 289,590 | 3,124 | 40,997 | 5,164 |
| Operating Expenses | 355,154 | 242,850 | 162,067 | 105,645 | 73,294 |
| Operating Income | -354,435 | 46,740 | -158,943 | -64,648 | -68,130 |
| Interest Expense | 0 | 0 | 0 | 0 | 8,050 |
| Other Income | 6,379 | 20,566 | -5,485 | -1,960 | 53,462 |
| Pre-tax Income | -348,056 | 67,306 | -164,428 | -66,608 | -22,718 |
| Income Tax | 809 | 448 | 553 | 1,749 | 484 |
| Net Income Continuous | -348,865 | 66,858 | -164,981 | -68,357 | -23,202 |
| Minority Interests | N/A | N/A | N/A | N/A | -25 |
| Net Income | $-348,865 | $66,858 | $-164,981 | $-68,357 | $-23,177 |
| EPS Basic Total Ops | -5.29 | 1.23 | -3.44 | -1.71 | -1.89 |
| EPS Basic Continuous Ops | -5.29 | 1.23 | -3.44 | -1.71 | -1.89 |
| EPS Diluted Total Ops | -5.29 | 1.17 | -3.44 | -1.71 | -1.89 |
| EPS Diluted Continuous Ops | -5.29 | 1.17 | -3.44 | -1.71 | -1.89 |
| EPS Diluted Before Non-Recurring Items | -5.29 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-343,394 | $51,465 | $-155,424 | $-61,624 | $-67,205 |